TrialCancer causes & control : CCC2012

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas.

Jason A Zell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.